ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Six Centers Win Grants

July 11, 2003

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Neutron Answers Needed Soon, Kligerman Says

May 6, 1983